$13 is going to be the new floor moving forward, IMHO
If this level becomes the new floor it will most likely serve as the pull back (or correction) support level after Japan approval . That means working backwards if we correct 20 - 30% from the high, (which is normal) the approval should take us between $15.60 to $16.9. Since my target has always been to sell my shares at $16.50, I am right in the sweet spot. This is how you use the math and previous results to your advantage. I usually charge for this information but consider it my gift to all this year! I am a long investor and will buy back in at $13 after we retrace and wait for more catalysts in 2014.
At every stage of a stock movement there is a point of support. We have many so far as more catalysts get revealed. This is where I see the stock sticking before and after approval from Japan. Of course there will be a pop on the news that will last a few days but then right back to where we are. An approval means something in the long term, NPT the short term. It takes years to get through the NCE review, Marketing and sales to where we have a good beat on the drugs effectiveness. Just one man's observations. If you don't agree, that's fine.